Table 1.

Comparison on the Baseline Characteristic of Responders and Non-Responders [n (%)]

Characteristics		Responders	Non-responders	P-value
		(PR)	(SD+PD)	(Fisher’s exact test)
	N=26	n= 2	n= 24
Gender
Male	9 (34.6)	1 (11.1)	8 (88.9)	1.000
Female	17 (65.4)	1 (5.9)	16 (94.1)
Age (year)
Median (range)	61.5 (44-89)
< 65 Year	14 (53.8)	0 (0.0)	14 (100.0)	0.203
≥ 65 Year	12 (46.2)	2 (16.7)	10 (83.3)
Extent of disease
Locally advanced	7 (26.9)	0 (0.0)	7 (100.0)	0.395*
Metastatic	14 (53.8)	2 (14.3)	12 (85.7)
Mixed	5 (19.2)	0 (0.0)	5 (100.0)
Primary tumor site
Cholangiocarcinoma	22 (84.6)	2 (9.1)	20 (90.9)	1.000
Gallbladder	4 (15.4)	0 (0.0)	4 (100.0)
Performance status(ECOG)
0	4 (15.4)	0 (0.0)	4 (100.0)	0.773*
1	21 (80.8)	2 (9.5)	19 (90.5)
2	1 (3.8)	0 (0.0)	1 (100.0)
Chemotherapeutic Regimens
Gemcitabine/Cisplatin	20 (76.9)	1 (5.0)	19 (95.0)	0.415
Gemcitabine/Carboplatin	6 (23.1)	1 (16.7)	5 (83.3)

^*-Chi-square test